Shares of Viatris Inc. VTRS slipped 1.03% to $10.62 Monday, on what proved to be an all-around positive trading session for ...

Shares of Viatris Inc. VTRS rose 1.89% to $10.80 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6,115.07 and the ...

Viatris, formed from Mylan and Pfizer's Established Brands, has faced stock price volatility since its inception in 2020. I rated Viatris a "Buy" last October, based on management's completion of ...

David Einhorn's Greenlight Capital opened new positions in Centene (CNC), with about 871K shares, and Acadia Healthcare ...

Let’s dig into the relative performance of Amphastar Pharmaceuticals (NASDAQ:AMPH) and its peers as we unravel the now-completed Q3 generic pharmaceuticals earnings season. The generic pharmaceutical ...

Pancreatic enzyme replacement therapy (Pert) provides the enzymes people affected by pancreatic cancer need to absorb ...

Viatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn (a division of Pfizer) in ...

In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against the other high-yield dividend stocks. Dividend stocks have been investors’ favorites for a long ...

Occasionally, treatments come along that are of greater interest to patients than to doctors.Drops for treating presbyopia ...